Managers / Q4 2018 · view latest →
SCHWARTZ INVESTMENT COUNSEL INC
CIK 0000909151 · 801 W. ANN ARBOR TRAIL, SUITE 244, PLYMOUTH, MI, 48170 · 734-455-7777
Summary
Schwartz Investment Counsel Inc reported $1.6B in U.S.-listed holdings across 126 positions for Q4 2018.
Its largest position, Medtronic, represents 3.9% of the portfolio.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 77.0% · $1.3B
- Other · 14.7% · $238M
- ADR · 4.2% · $68M
- REIT · 2.0% · $33M
- Royalty Trst · 1.2% · $19M
- Other · 0.9% · $15M
Quarter-over-Quarter Changes full breakdown →
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| MEDTRONIC INC | NEW | +689.3K | 689.3K | +$63M | $63M |
| TXNTEXAS INSTRS INC | NEW | +522.3K | 522.3K | +$49M | $49M |
| ZBHZIMMER BIOMET HLDGS INC | NEW | +470.9K | 470.9K | +$49M | $49M |
| LOWLOWES COS INC | NEW | +508.7K | 508.7K | +$47M | $47M |
| HXLHEXCEL CORP NEW | NEW | +715.0K | 715.0K | +$41M | $41M |
| BF/BBROWN FORMAN CORP | NEW | +844.3K | 844.3K | +$40M | $40M |
| VVISA INC | NEW | +303.8K | 303.8K | +$40M | $40M |
| CTSHCOGNIZANT TECHNOLOGY SOLUTIO | NEW | +609.0K | 609.0K | +$39M | $39M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2018
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $2.8B | 129 | May 4, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $2.9B | 133 | Feb 4, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $3.0B | 130 | Oct 29, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $3.0B | 124 | Jul 30, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $2.9B | 126 | Apr 24, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $2.8B | 128 | Jan 29, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $2.8B | 131 | Oct 23, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $2.7B | 134 | Jul 24, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $2.7B | 140 | May 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $2.6B | 138 | Jan 26, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $2.3B | 138 | Oct 17, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $2.4B | 137 | Aug 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $2.3B | 139 | May 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $2.2B | 137 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.9B | 132 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $2.1B | 131 | Aug 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $2.4B | 134 | May 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $2.6B | 137 | Feb 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $2.4B | 134 | Nov 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $2.5B | 135 | Aug 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $2.3B | 130 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $2.2B | 127 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $2.0B | 128 | Nov 17, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2020 | $1.8B | 125 | Aug 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $1.5B | 113 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $2.1B | 122 | Feb 4, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $2.0B | 126 | Oct 29, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $2.0B | 126 | Jul 24, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.9B | 121 | May 2, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $1.6B | 126 | Feb 13, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.